Anti-GD3 antibody + TNF-α induces haemorrhagic tumour necrosis

Gespeichert in:

Format:	E-Artikel
Sprache:	Englisch

Erschienen:	1994

Schlagwörter:	Metastatic Melanoma Adrenal Insufficiency Tumour Lysis Syndrome Infiltrate Tumour Adverse Sequela

Anmerkung:	© Adis International Ltd 1994

Übergeordnetes Werk:	Enthalten in: Inpharma weekly - Auckland : ADIS internat., 1975, 924(1994), 1 vom: Feb., Seite 10-10
Übergeordnetes Werk:	volume:924 ; year:1994 ; number:1 ; month:02 ; pages:10-10

Links:	Volltext

DOI / URN:	10.2165/00128413-199409240-00020

Katalog-ID:	SPR036127981

Internformat


LEADER	01000caa a22002652 4500
001	SPR036127981
003	DE-627
005	20230519110708.0
007	cr uuu---uuuuu
008	201007s1994 xx \|\|\|\|\|o 00\| \|\|eng c
024	7		\|a 10.2165/00128413-199409240-00020 \|2 doi
035			\|a (DE-627)SPR036127981
035			\|a (SPR)00128413-199409240-00020-e
040			\|a DE-627 \|b ger \|c DE-627 \|e rakwb
041			\|a eng
245	1	0	\|a Anti-GD3 antibody + TNF-α induces haemorrhagic tumour necrosis
264		1	\|c 1994
336			\|a Text \|b txt \|2 rdacontent
337			\|a Computermedien \|b c \|2 rdamedia
338			\|a Online-Ressource \|b cr \|2 rdacarrier
500			\|a © Adis International Ltd 1994
650		4	\|a Metastatic Melanoma \|7 (dpeaa)DE-He213
650		4	\|a Adrenal Insufficiency \|7 (dpeaa)DE-He213
650		4	\|a Tumour Lysis Syndrome \|7 (dpeaa)DE-He213
650		4	\|a Infiltrate Tumour \|7 (dpeaa)DE-He213
650		4	\|a Adverse Sequela \|7 (dpeaa)DE-He213
773	0	8	\|i Enthalten in \|t Inpharma weekly \|d Auckland : ADIS internat., 1975 \|g 924(1994), 1 vom: Feb., Seite 10-10 \|w (DE-627)373977859 \|w (DE-600)2127607-9 \|x 2230-6056 \|7 nnns
773	1	8	\|g volume:924 \|g year:1994 \|g number:1 \|g month:02 \|g pages:10-10
856	4	0	\|u https://dx.doi.org/10.2165/00128413-199409240-00020 \|z lizenzpflichtig \|3 Volltext
912			\|a GBV_USEFLAG_A
912			\|a SYSFLAG_A
912			\|a GBV_SPRINGER
912			\|a SSG-OLC-PHA
912			\|a GBV_ILN_20
951			\|a AR
952			\|d 924 \|j 1994 \|e 1 \|c 02 \|h 10-10

Indexfelder

matchkey_str	article:22306056:1994----::nidatbdtfnueheorai
hierarchy_sort_str	1994
publishDate	1994
allfields	10.2165/00128413-199409240-00020 doi (DE-627)SPR036127981 (SPR)00128413-199409240-00020-e DE-627 ger DE-627 rakwb eng Anti-GD3 antibody + TNF-α induces haemorrhagic tumour necrosis 1994 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier © Adis International Ltd 1994 Metastatic Melanoma (dpeaa)DE-He213 Adrenal Insufficiency (dpeaa)DE-He213 Tumour Lysis Syndrome (dpeaa)DE-He213 Infiltrate Tumour (dpeaa)DE-He213 Adverse Sequela (dpeaa)DE-He213 Enthalten in Inpharma weekly Auckland : ADIS internat., 1975 924(1994), 1 vom: Feb., Seite 10-10 (DE-627)373977859 (DE-600)2127607-9 2230-6056 nnns volume:924 year:1994 number:1 month:02 pages:10-10 https://dx.doi.org/10.2165/00128413-199409240-00020 lizenzpflichtig Volltext GBV_USEFLAG_A SYSFLAG_A GBV_SPRINGER SSG-OLC-PHA GBV_ILN_20 AR 924 1994 1 02 10-10
spelling	10.2165/00128413-199409240-00020 doi (DE-627)SPR036127981 (SPR)00128413-199409240-00020-e DE-627 ger DE-627 rakwb eng Anti-GD3 antibody + TNF-α induces haemorrhagic tumour necrosis 1994 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier © Adis International Ltd 1994 Metastatic Melanoma (dpeaa)DE-He213 Adrenal Insufficiency (dpeaa)DE-He213 Tumour Lysis Syndrome (dpeaa)DE-He213 Infiltrate Tumour (dpeaa)DE-He213 Adverse Sequela (dpeaa)DE-He213 Enthalten in Inpharma weekly Auckland : ADIS internat., 1975 924(1994), 1 vom: Feb., Seite 10-10 (DE-627)373977859 (DE-600)2127607-9 2230-6056 nnns volume:924 year:1994 number:1 month:02 pages:10-10 https://dx.doi.org/10.2165/00128413-199409240-00020 lizenzpflichtig Volltext GBV_USEFLAG_A SYSFLAG_A GBV_SPRINGER SSG-OLC-PHA GBV_ILN_20 AR 924 1994 1 02 10-10
allfields_unstemmed	10.2165/00128413-199409240-00020 doi (DE-627)SPR036127981 (SPR)00128413-199409240-00020-e DE-627 ger DE-627 rakwb eng Anti-GD3 antibody + TNF-α induces haemorrhagic tumour necrosis 1994 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier © Adis International Ltd 1994 Metastatic Melanoma (dpeaa)DE-He213 Adrenal Insufficiency (dpeaa)DE-He213 Tumour Lysis Syndrome (dpeaa)DE-He213 Infiltrate Tumour (dpeaa)DE-He213 Adverse Sequela (dpeaa)DE-He213 Enthalten in Inpharma weekly Auckland : ADIS internat., 1975 924(1994), 1 vom: Feb., Seite 10-10 (DE-627)373977859 (DE-600)2127607-9 2230-6056 nnns volume:924 year:1994 number:1 month:02 pages:10-10 https://dx.doi.org/10.2165/00128413-199409240-00020 lizenzpflichtig Volltext GBV_USEFLAG_A SYSFLAG_A GBV_SPRINGER SSG-OLC-PHA GBV_ILN_20 AR 924 1994 1 02 10-10
allfieldsGer	10.2165/00128413-199409240-00020 doi (DE-627)SPR036127981 (SPR)00128413-199409240-00020-e DE-627 ger DE-627 rakwb eng Anti-GD3 antibody + TNF-α induces haemorrhagic tumour necrosis 1994 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier © Adis International Ltd 1994 Metastatic Melanoma (dpeaa)DE-He213 Adrenal Insufficiency (dpeaa)DE-He213 Tumour Lysis Syndrome (dpeaa)DE-He213 Infiltrate Tumour (dpeaa)DE-He213 Adverse Sequela (dpeaa)DE-He213 Enthalten in Inpharma weekly Auckland : ADIS internat., 1975 924(1994), 1 vom: Feb., Seite 10-10 (DE-627)373977859 (DE-600)2127607-9 2230-6056 nnns volume:924 year:1994 number:1 month:02 pages:10-10 https://dx.doi.org/10.2165/00128413-199409240-00020 lizenzpflichtig Volltext GBV_USEFLAG_A SYSFLAG_A GBV_SPRINGER SSG-OLC-PHA GBV_ILN_20 AR 924 1994 1 02 10-10
allfieldsSound	10.2165/00128413-199409240-00020 doi (DE-627)SPR036127981 (SPR)00128413-199409240-00020-e DE-627 ger DE-627 rakwb eng Anti-GD3 antibody + TNF-α induces haemorrhagic tumour necrosis 1994 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier © Adis International Ltd 1994 Metastatic Melanoma (dpeaa)DE-He213 Adrenal Insufficiency (dpeaa)DE-He213 Tumour Lysis Syndrome (dpeaa)DE-He213 Infiltrate Tumour (dpeaa)DE-He213 Adverse Sequela (dpeaa)DE-He213 Enthalten in Inpharma weekly Auckland : ADIS internat., 1975 924(1994), 1 vom: Feb., Seite 10-10 (DE-627)373977859 (DE-600)2127607-9 2230-6056 nnns volume:924 year:1994 number:1 month:02 pages:10-10 https://dx.doi.org/10.2165/00128413-199409240-00020 lizenzpflichtig Volltext GBV_USEFLAG_A SYSFLAG_A GBV_SPRINGER SSG-OLC-PHA GBV_ILN_20 AR 924 1994 1 02 10-10
language	English
source	Enthalten in Inpharma weekly 924(1994), 1 vom: Feb., Seite 10-10 volume:924 year:1994 number:1 month:02 pages:10-10
sourceStr	Enthalten in Inpharma weekly 924(1994), 1 vom: Feb., Seite 10-10 volume:924 year:1994 number:1 month:02 pages:10-10
format_phy_str_mv	Article
institution	findex.gbv.de
topic_facet	Metastatic Melanoma Adrenal Insufficiency Tumour Lysis Syndrome Infiltrate Tumour Adverse Sequela
isfreeaccess_bool	false
container_title	Inpharma weekly
publishDateDaySort_date	1994-02-01T00:00:00Z
hierarchy_top_id	373977859
id	SPR036127981
language_de	englisch
fullrecord	<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">SPR036127981</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230519110708.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">201007s1994 xx \|\|\|\|\|o 00\| \|\|eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.2165/00128413-199409240-00020</subfield><subfield code="2">doi</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)SPR036127981</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(SPR)00128413-199409240-00020-e</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Anti-GD3 antibody + TNF-α induces haemorrhagic tumour necrosis</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">1994</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">Text</subfield><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">Computermedien</subfield><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">Online-Ressource</subfield><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">© Adis International Ltd 1994</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Metastatic Melanoma</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Adrenal Insufficiency</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Tumour Lysis Syndrome</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Infiltrate Tumour</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Adverse Sequela</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">Enthalten in</subfield><subfield code="t">Inpharma weekly</subfield><subfield code="d">Auckland : ADIS internat., 1975</subfield><subfield code="g">924(1994), 1 vom: Feb., Seite 10-10</subfield><subfield code="w">(DE-627)373977859</subfield><subfield code="w">(DE-600)2127607-9</subfield><subfield code="x">2230-6056</subfield><subfield code="7">nnns</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:924</subfield><subfield code="g">year:1994</subfield><subfield code="g">number:1</subfield><subfield code="g">month:02</subfield><subfield code="g">pages:10-10</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://dx.doi.org/10.2165/00128413-199409240-00020</subfield><subfield code="z">lizenzpflichtig</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_SPRINGER</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SSG-OLC-PHA</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_20</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">924</subfield><subfield code="j">1994</subfield><subfield code="e">1</subfield><subfield code="c">02</subfield><subfield code="h">10-10</subfield></datafield></record></collection>
ppnlink_with_tag_str_mv	@@773@@(DE-627)373977859
format	electronic Article
delete_txt_mv	keep
collection	springer
remote_str	true
illustrated	Not Illustrated
issn	2230-6056
topic_title	Anti-GD3 antibody + TNF-α induces haemorrhagic tumour necrosis Metastatic Melanoma (dpeaa)DE-He213 Adrenal Insufficiency (dpeaa)DE-He213 Tumour Lysis Syndrome (dpeaa)DE-He213 Infiltrate Tumour (dpeaa)DE-He213 Adverse Sequela (dpeaa)DE-He213
topic	misc Metastatic Melanoma misc Adrenal Insufficiency misc Tumour Lysis Syndrome misc Infiltrate Tumour misc Adverse Sequela
spellingShingle	misc Metastatic Melanoma misc Adrenal Insufficiency misc Tumour Lysis Syndrome misc Infiltrate Tumour misc Adverse Sequela Anti-GD3 antibody + TNF-α induces haemorrhagic tumour necrosis
topic_unstemmed	misc Metastatic Melanoma misc Adrenal Insufficiency misc Tumour Lysis Syndrome misc Infiltrate Tumour misc Adverse Sequela
topic_browse	misc Metastatic Melanoma misc Adrenal Insufficiency misc Tumour Lysis Syndrome misc Infiltrate Tumour misc Adverse Sequela
format_facet	Elektronische Aufsätze Aufsätze Elektronische Ressource
format_main_str_mv	Text Zeitschrift/Artikel
carriertype_str_mv	cr
hierarchy_parent_title	Inpharma weekly
hierarchy_parent_id	373977859
hierarchy_top_title	Inpharma weekly
isfreeaccess_txt	false
familylinks_str_mv	(DE-627)373977859 (DE-600)2127607-9
title	Anti-GD3 antibody + TNF-α induces haemorrhagic tumour necrosis
ctrlnum	(DE-627)SPR036127981 (SPR)00128413-199409240-00020-e
title_full	Anti-GD3 antibody + TNF-α induces haemorrhagic tumour necrosis
journal	Inpharma weekly
journalStr	Inpharma weekly
lang_code	eng
isOA_bool	false
recordtype	marc
publishDateSort	1994
contenttype_str_mv	txt
container_start_page	10
container_volume	924
format_se	Elektronische Aufsätze
doi_str_mv	10.2165/00128413-199409240-00020
title_sort	anti-gd3 antibody + tnf-α induces haemorrhagic tumour necrosis
title_auth	Anti-GD3 antibody + TNF-α induces haemorrhagic tumour necrosis
abstract	© Adis International Ltd 1994
abstractGer	© Adis International Ltd 1994
abstract_unstemmed	© Adis International Ltd 1994
collection_details	GBV_USEFLAG_A SYSFLAG_A GBV_SPRINGER SSG-OLC-PHA GBV_ILN_20
container_issue	1
title_short	Anti-GD3 antibody + TNF-α induces haemorrhagic tumour necrosis
url	https://dx.doi.org/10.2165/00128413-199409240-00020
remote_bool	true
ppnlink	373977859
mediatype_str_mv	c
isOA_txt	false
hochschulschrift_bool	false
doi_str	10.2165/00128413-199409240-00020
up_date	2024-07-03T16:35:21.162Z
_version_	1803576432304062464
fullrecord_marcxml	<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">SPR036127981</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230519110708.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">201007s1994 xx \|\|\|\|\|o 00\| \|\|eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.2165/00128413-199409240-00020</subfield><subfield code="2">doi</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)SPR036127981</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(SPR)00128413-199409240-00020-e</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Anti-GD3 antibody + TNF-α induces haemorrhagic tumour necrosis</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">1994</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">Text</subfield><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">Computermedien</subfield><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">Online-Ressource</subfield><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">© Adis International Ltd 1994</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Metastatic Melanoma</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Adrenal Insufficiency</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Tumour Lysis Syndrome</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Infiltrate Tumour</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Adverse Sequela</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">Enthalten in</subfield><subfield code="t">Inpharma weekly</subfield><subfield code="d">Auckland : ADIS internat., 1975</subfield><subfield code="g">924(1994), 1 vom: Feb., Seite 10-10</subfield><subfield code="w">(DE-627)373977859</subfield><subfield code="w">(DE-600)2127607-9</subfield><subfield code="x">2230-6056</subfield><subfield code="7">nnns</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:924</subfield><subfield code="g">year:1994</subfield><subfield code="g">number:1</subfield><subfield code="g">month:02</subfield><subfield code="g">pages:10-10</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://dx.doi.org/10.2165/00128413-199409240-00020</subfield><subfield code="z">lizenzpflichtig</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_SPRINGER</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SSG-OLC-PHA</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_20</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">924</subfield><subfield code="j">1994</subfield><subfield code="e">1</subfield><subfield code="c">02</subfield><subfield code="h">10-10</subfield></datafield></record></collection>
score	7.4000216

Nicht das Richtige dabei?

Schreiben Sie uns!

Anti-GD3 antibody + TNF-α induces haemorrhagic tumour necrosis

Nicht das Richtige dabei?

Zugang & Verfügbarkeit

Vorhandene Bände

Nicht das Richtige dabei?